Neuropathic Pain Market
Neuropathic Pain Market : Table of Content
- Report code : PMRREP4149 |
- Industry : Life Sciences & Transformational Health |
- Published On : Jan-2020 |
- Pages : 182 Pages |
-
Format :
1. Executive Summary
1.1. Global Market Outlook
1.2. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Dynamics
3.1. Macro-Economic Factors
3.2. Drivers
3.2.1. Supply Side Drivers
3.2.2. Demand Side Drivers
3.3. Restraints
3.4. Opportunities
3.5. Trends
4. Key Inclusions
4.1. Clinical Trials
5. Global Neuropathic Pain Management Market Value Analysis 2014-2018 and Forecast, 2019-2029
5.1. Historical Market Value (US$ Mn) Analysis, 2014-2018
5.2. Current and Future Market Value (US$ Mn) Projections, 2019-2029
5.2.1. Y-o-Y Growth Trend Analysis
5.2.2. Absolute $ Opportunity Analysis
6. Global Neuropathic Pain Management Market Analysis 2014-2018 and Forecast 2019-2029, by Drug Class
6.1. Introduction / Key Findings
6.2. Historical Market Size (US$ Mn) Analysis By Drug Class, 2014-2018
6.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Drug Class, 2019 - 2029
6.3.1. Tricyclic Anti-Depressants
6.3.2. Anticonvulsants
6.3.3. SNRI's
6.3.4. Capsaicin Cream
6.3.5. Local Anaesthesia
6.3.6. Opioids
6.3.7. Steroids
6.3.8. Others
6.4. Market Attractiveness Analysis By Drug Class
7. Global Neuropathic Pain Management Market Analysis 2014-2018 and Forecast 2019-2029, by Indication
7.1. Introduction / Key Findings
7.2. Historical Market Size (US$ Mn) Analysis By Indication, 2014-2018
7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Indication, 2019 - 2029
7.3.1. Diabetic Neuropathy
7.3.2. Trigeminal Neuralgia
7.3.3. Post-Herpetic Neuralgia
7.3.4. Chemotherapy-Induced Peripheral Neuropathy
7.3.5. Others
7.4. Market Attractiveness Analysis By Indication
8. Global Neuropathic Pain Management Market Analysis 2014-2018 and Forecast 2019-2029, by Distribution Channel
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2014-2018
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2019 - 2029
8.3.1. Retail Pharmacies
8.3.2. Hospital Pharmacies
8.3.3. Online Pharmacies
8.4. Market Attractiveness Analysis By Distribution Channel
9. Global Neuropathic Pain Management Market Analysis 2014-2018 and Forecast 2019-2029, by Region
9.1. Introduction
9.2. Historical Market Size (US$ Mn) Analysis By Region, 2014-2018
9.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2019 - 2029
9.3.1. North America
9.3.2. Latin America
9.3.3. Europe
9.3.4. Asia Pacific
9.3.5. Middle East and Africa
9.4. Market Attractiveness Analysis By Region
10. North America Neuropathic Pain Management Market Analysis 2014-2018 and Forecast 2019-2029
10.1. Introduction
10.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018
10.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2029
10.3.1. By Country
10.3.1.1. U.S.
10.3.1.2. Canada
10.3.2. By Drug Class
10.3.3. By Indication
10.3.4. By Distribution Channel
10.4. Market Attractiveness Analysis
10.5. Key Impact Analysis
11. Latin America Neuropathic Pain Management Market Analysis 2014-2018 and Forecast 2019-2029
11.1. Introduction
11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018
11.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2029
11.3.1. By Country
11.3.1.1. Brazil
11.3.1.2. Mexico
11.3.1.3. Argentina
11.3.1.4. Rest of Latin America
11.3.2. By Drug Class
11.3.3. By Indication
11.3.4. By Distribution Channel
11.4. Market Attractiveness Analysis
11.5. Key Impact Analysis
12. Europe Neuropathic Pain Management Market Analysis 2014-2018 and Forecast 2019-2029
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018
12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2029
12.3.1. By Country
12.3.1.1. U.K.
12.3.1.2. Germany
12.3.1.3. France
12.3.1.4. Italy
12.3.1.5. Spain
12.3.1.6. Russia
12.3.1.7. Rest of Europe
12.3.2. By Drug Class
12.3.3. By Indication
12.3.4. By Distribution Channel
12.4. Market Attractiveness Analysis
12.5. Key Impact Analysis
13. Asia Pacific Neuropathic Pain Management Market Analysis 2014-2018 and Forecast 2019-2029
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018
13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2029
13.3.1. By Country
13.3.1.1. China
13.3.1.2. India
13.3.1.3. Australia and NZ
13.3.1.4. ASEAN
13.3.1.5. Rest of Asia Pacific
13.3.2. By Drug Class
13.3.3. By Indication
13.3.4. By Distribution Channel
13.4. Market Attractiveness Analysis
13.5. Key Impact Analysis
14. Middle East and Africa Neuropathic Pain Management Market Analysis 2014-2018 and Forecast 2019-2029
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018
14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2029
14.3.1. By Country
14.3.1.1. GCC Countries
14.3.1.2. South Africa
14.3.1.3. Rest of MEA
14.3.2. By Drug Class
14.3.3. By Indication
14.3.4. By Distribution Channel
14.4. Market Attractiveness Analysis
14.5. Key Impact Analysis
15. Competition Analysis
15.1. Competition Dashboard
15.2. Competition Deep Dive
15.2.1. Pfizer Inc.
15.2.1.1. Company Overview
15.2.1.2. Segment Overview
15.2.1.3. ProductOfferings
15.2.1.4. Financial Analysis
15.2.1.5. Key Developments
15.2.1.6. Strategy Overview
15.2.2. Johnson & Johnson Services, Inc.
15.2.2.1. Company Overview
15.2.2.2. Segment Overview
15.2.2.3. ProductOfferings
15.2.2.4. Financial Analysis
15.2.2.5. Key Developments
15.2.2.6. Strategy Overview
15.2.3. Bristol-Myers Squibb Company
15.2.3.1. Company Overview
15.2.3.2. Segment Overview
15.2.3.3. ProductOfferings
15.2.3.4. Financial Analysis
15.2.3.5. Key Developments
15.2.3.6. Strategy Overview
15.2.4. Sanofi S.A
15.2.4.1. Company Overview
15.2.4.2. Segment Overview
15.2.4.3. ProductOfferings
15.2.4.4. Financial Analysis
15.2.4.5. Key Developments
15.2.4.6. Strategy Overview
15.2.5. GlaxoSmithKline plc
15.2.5.1. Company Overview
15.2.5.2. Segment Overview
15.2.5.3. ProductOfferings
15.2.5.4. Financial Analysis
15.2.5.5. Key Developments
15.2.5.6. Strategy Overview
15.2.6. Eli Lilly and Company
15.2.6.1. Company Overview
15.2.6.2. Segment Overview
15.2.6.3. ProductOfferings
15.2.6.4. Financial Analysis
15.2.6.5. Key Developments
15.2.6.6. Strategy Overview
15.2.7. Teva Pharmaceutical Industries Ltd
15.2.7.1. Company Overview
15.2.7.2. Segment Overview
15.2.7.3. ProductOfferings
15.2.7.4. Financial Analysis
15.2.7.5. Key Developments
15.2.7.6. Strategy Overview
15.2.8. Baxter International Inc
15.2.8.1. Company Overview
15.2.8.2. Segment Overview
15.2.8.3. ProductOfferings
15.2.8.4. Financial Analysis
15.2.8.5. Key Developments
15.2.8.6. Strategy Overview
16. Assumptions and Acronyms Used
17. Research Methodology
List of Tables
Table 01: Global Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Drug Class
Table 02: Global Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Indication
Table 03: Global Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Distribution Channel
Table 04: Global Neuropathic Pain Management Size (US$ Mn) 2014-2018 and Forecast 2019-2029 By Region,
Table 05: North America Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country
Table 06: North America Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Drug Class
Table 07: North America Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Indication
Table 08: North America Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Distribution Channel
Table 09: Latin America Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country
Table 10: Latin America Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Drug Class
Table 11: Latin America Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Indication
Table 12: Latin America Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Distribution Channel
Table 13: Europe Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country
Table 14: Europe Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Drug Class
Table 15: Europe Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Indication
Table 16: Europe Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Distribution Channel
Table 17: Asia-Pacific Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country
Table 18: Asia-Pacific Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Drug Class
Table 19: Asia-Pacific Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Indication
Table 20: Asia-Pacific Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Distribution Channel
Table 21: MEA Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country
Table 22: MEA Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Drug Class
Table 23: MEA Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Indication
Table 24: MEA Neuropathic Pain Management Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Distribution Channel
List of Figures
Figure 01: Global Neuropathic Pain Management Market Value Share By Drug Class (2019 E)
Figure 02: Global Neuropathic Pain Management Market Value Share By Indication (2019 E)
Figure 03: Global Neuropathic Pain Management Market Value Share By Distribution Channel (2019 E)
Figure 04: Global Neuropathic Pain Management Market Value Share By Region (2019 E)
Figure 05: Global Neuropathic Pain Management Market Value Analysis (US$ Mn), 2014-2018
Figure 06: Global Neuropathic Pain Management Market Value Analysis (US$ Mn), 2019-2029
Figure 07: Global Neuropathic Pain Management Market Absolute $ Opportunity, 2018 - 2026
Figure 08: Global Neuropathic Pain Management Market Share Analysis (%), By Drug Class, 2018 & 2026
Figure 09: Global Neuropathic Pain Management Market Y-o-Y Analysis (%), By Drug Class, 2019-2029
Figure 10: Global Neuropathic Pain Management Market Attractiveness Analysis By Drug Class, 2019-2029
Figure 11: Global Neuropathic Pain Management Market Share Analysis (%), By Indication , 2018 & 2026
Figure 12: Global Neuropathic Pain Management Market Y-o-Y Analysis (%), By Indication , 2019-2029
Figure 13: Global Neuropathic Pain Management Market Attractiveness Analysis By Indication, 2019-2029
Figure 14: Global Neuropathic Pain Management Market Share Analysis (%), By Distribution Channel, 2018 & 2026
Figure 15: Global Neuropathic Pain Management Market Y-o-Y Analysis (%), By Distribution Channel, 2019-2029
Figure 16: Global Neuropathic Pain Management Market Attractiveness Analysis By Distribution Channel, 2019-2029
Figure 17: Global Neuropathic Pain Management Market Share Analysis (%), By Region, 2018 & 2026
Figure 18: Global Neuropathic Pain Management Market Y-o-Y Analysis (%), By Region, 2019-2029
Figure 19: Global Neuropathic Pain Management Market Attractiveness Analysis By Region, 2019-2029
Figure 20: North America Neuropathic Pain Management Market Value Share By Drug Class (2019 E)
Figure 21: North America Neuropathic Pain Management Market Value Share By Indication (2019 E)
Figure 22: North America Neuropathic Pain Management Market Value Share By Distribution Channel (2019 E)
Figure 23: North America Neuropathic Pain Management Market Value Share By Country (2019 E)
Figure 24: North America Neuropathic Pain Management Market Value Analysis (US$ Mn), 2014-2018
Figure 25: North America Neuropathic Pain Management Market Value Analysis (US$ Mn), 2019-2029
Figure 26: U.S. Neuropathic Pain Management Market Value Analysis (US$ Mn), 2014-2018
Figure 27: U.S. Neuropathic Pain Management Market Value Analysis (US$ Mn), 2019-2029
Figure 28: Canada Neuropathic Pain Management Market Value Analysis (US$ Mn), 2014-2018
Figure 29: Canada Neuropathic Pain Management Market Value Analysis (US$ Mn), 2019-2029
Figure 30: North America Neuropathic Pain Management Market Attractiveness Analysis By Drug Class, 2019-2029
Figure 31: North America Neuropathic Pain Management Market Attractiveness Analysis By Indication, 2019-2029
Figure 32: North America Neuropathic Pain Management Market Attractiveness Analysis By Distribution Channel, 2019-2029
Figure 33: North America Neuropathic Pain Management Market Attractiveness Analysis By Country, 2019-2029
Figure 34: Latin America Neuropathic Pain Management Market Value Share By Drug Class (2019 E)
Figure 35: Latin America Neuropathic Pain Management Market Value Share By Indication (2019 E)
Figure 36: Latin America Neuropathic Pain Management Market Value Share By Distribution Channel (2019 E)
Figure 37: Latin America Neuropathic Pain Management Market Value Share By Country (2019 E)
Figure 38: Latin America Neuropathic Pain Management Market Value Analysis (US$ Mn), 2014-2018
Figure 39: Latin America Neuropathic Pain Management Market Value Analysis (US$ Mn), 2019-2029
Figure 40: Brazil Neuropathic Pain Management Market Value Analysis (US$ Mn), 2014-2018
Figure 41: Brazil Neuropathic Pain Management Market Value Analysis (US$ Mn), 2019-2029
Figure 42: Mexico Neuropathic Pain Management Market Value Analysis (US$ Mn), 2014-2018
Figure 43: Mexico Neuropathic Pain Management Market Value Analysis (US$ Mn), 2019-2029
Figure 44: Argentina Neuropathic Pain Management Market Value Analysis (US$ Mn), 2014-2018
Figure 45: Argentina Neuropathic Pain Management Market Value Analysis (US$ Mn), 2019-2029
Figure 46: Rest of Latin America Neuropathic Pain Management Market Value Analysis (US$ Mn), 2014-2018
Figure 47: Rest of Latin America Neuropathic Pain Management Market Value Analysis (US$ Mn), 2019-2029
Figure 48: Latin America Neuropathic Pain Management Market Attractiveness Analysis By Drug Class, 2019-2029
Figure 49: Latin America Neuropathic Pain Management Market Attractiveness Analysis By Indication, 2019-2029
Figure 50: Latin America Neuropathic Pain Management Market Attractiveness Analysis By Distribution Channel, 2019-2029
Figure 51: Latin America Neuropathic Pain Management Market Attractiveness Analysis By Country, 2019-2029
Figure 52: Europe Neuropathic Pain Management Market Value Share By Drug Class (2019 E)
Figure 53: Europe Neuropathic Pain Management Market Value Share By Indication (2019 E)
Figure 54: Europe Neuropathic Pain Management Market Value Share By Distribution Channel (2019 E)
Figure 55: Europe Neuropathic Pain Management Market Value Share By Country (2019 E)
Figure 56: Europe Neuropathic Pain Management Market Value Analysis (US$ Mn), 2014-2018
Figure 57: Europe Neuropathic Pain Management Market Value Analysis (US$ Mn), 2019-2029
Figure 58: U.K. Neuropathic Pain Management Market Value Analysis (US$ Mn), 2014-2018
Figure 59: U.K. Neuropathic Pain Management Market Value Analysis (US$ Mn), 2019-2029
Figure 60: Germany Neuropathic Pain Management Market Value Analysis (US$ Mn), 2014-2018
Figure 61: Germany Neuropathic Pain Management Market Value Analysis (US$ Mn), 2019-2029
Figure 62: France Neuropathic Pain Management Market Value Analysis (US$ Mn), 2014-2018
Figure 63: France Neuropathic Pain Management Market Value Analysis (US$ Mn), 2019-2029
Figure 64: Italy Neuropathic Pain Management Market Value Analysis (US$ Mn), 2014-2018
Figure 65: Italy Neuropathic Pain Management Market Value Analysis (US$ Mn), 2019-2029
Figure 66: Spain Neuropathic Pain Management Market Value Analysis (US$ Mn), 2014-2018
Figure 67: Spain Neuropathic Pain Management Market Value Analysis (US$ Mn), 2019-2029
Figure 68: Russia Neuropathic Pain Management Market Value Analysis (US$ Mn), 2014-2018
Figure 69: Russia Neuropathic Pain Management Market Value Analysis (US$ Mn), 2019-2029
Figure 70: Rest of Europe Neuropathic Pain Management Market Value Analysis (US$ Mn), 2014-2018
Figure 71: Rest of Europe Neuropathic Pain Management Market Value Analysis (US$ Mn), 2019-2029
Figure 72: Europe Neuropathic Pain Management Market Attractiveness Analysis By Drug Class, 2019-2029
Figure 73: Europe Neuropathic Pain Management Market Attractiveness Analysis By Indication, 2019-2029
Figure 74: Europe Neuropathic Pain Management Market Attractiveness Analysis By Distribution Channel, 2019-2029
Figure 75: Europe Neuropathic Pain Management Market Attractiveness Analysis By Country, 2019-2029
Figure 76: Asia-Pacific Neuropathic Pain Management Market Value Share By Drug Class (2019 E)
Figure 77: Asia-Pacific Neuropathic Pain Management Market Value Share By Indication (2019 E)
Figure 78: Asia-Pacific Neuropathic Pain Management Market Value Share By Distribution Channel (2019 E)
Figure 79: Asia-Pacific Neuropathic Pain Management Market Value Share By Country (2019 E)
Figure 80: Asia-Pacific Neuropathic Pain Management Market Value Analysis (US$ Mn), 2014-2018
Figure 81: Asia-Pacific Neuropathic Pain Management Market Value Analysis (US$ Mn), 2019-2029
Figure 82: Japan Neuropathic Pain Management Market Value Analysis (US$ Mn), 2014-2018
Figure 83: Japan Neuropathic Pain Management Market Value Analysis (US$ Mn), 2019-2029
Figure 84: China Neuropathic Pain Management Market Value Analysis (US$ Mn), 2014-2018
Figure 85: China Neuropathic Pain Management Market Value Analysis (US$ Mn), 2019-2029
Figure 86: India Neuropathic Pain Management Market Value Analysis (US$ Mn), 2014-2018
Figure 87: India Neuropathic Pain Management Market Value Analysis (US$ Mn), 2019-2029
Figure 88: Australia & New Zealand Neuropathic Pain Management Market Value Analysis (US$ Mn), 2014-2018
Figure 89: Australia & New Zealand Neuropathic Pain Management Market Value Analysis (US$ Mn), 2019-2029
Figure 90: ASEAN Neuropathic Pain Management Market Value Analysis (US$ Mn), 2014-2018
Figure 91: ASEAN Neuropathic Pain Management Market Value Analysis (US$ Mn), 2019-2029
Figure 92: Rest of APAC Neuropathic Pain Management Market Value Analysis (US$ Mn), 2014-2018
Figure 93: Rest of APAC Neuropathic Pain Management Market Value Analysis (US$ Mn), 2019-2029
Figure 94: Asia-Pacific Neuropathic Pain Management Market Attractiveness Analysis By Drug Class, 2019-2029
Figure 95: Asia-Pacific Neuropathic Pain Management Market Attractiveness Analysis By Indication, 2019-2029
Figure 96: Asia-Pacific Neuropathic Pain Management Market Attractiveness Analysis By Distribution Channel, 2019-2029
Figure 97: Asia-Pacific Neuropathic Pain Management Market Attractiveness Analysis By Country, 2019-2029
Figure 98: MEA Neuropathic Pain Management Market Value Share By Drug Class (2019 E)
Figure 99: MEA Neuropathic Pain Management Market Value Share By Indication (2019 E)
Figure 100: MEA Neuropathic Pain Management Market Value Share By Distribution Channel (2019 E)
Figure 101: MEA Neuropathic Pain Management Market Value Share By Country (2019 E)
Figure 102: MEA Neuropathic Pain Management Market Value Analysis (US$ Mn), 2014-2018
Figure 103: MEA Neuropathic Pain Management Market Value Analysis (US$ Mn), 2019-2029
Figure 104: South Africa Neuropathic Pain Management Market Value Analysis (US$ Mn), 2014-2018
Figure 105: South Africa Neuropathic Pain Management Market Value Analysis (US$ Mn), 2019-2029
Figure 106: GCC Countries Neuropathic Pain Management Market Value Analysis (US$ Mn), 2014-2018
Figure 107: GCC Countries Neuropathic Pain Management Market Value Analysis (US$ Mn), 2019-2029
Figure 108: Rest of MEA Neuropathic Pain Management Market Value Analysis (US$ Mn), 2014-2018
Figure 109: Rest of MEA Neuropathic Pain Management Market Value Analysis (US$ Mn), 2019-2029
Figure 110: MEA Neuropathic Pain Management Market Attractiveness Analysis By Drug Class, 2019-2029
Figure 111: MEA Neuropathic Pain Management Market Attractiveness Analysis By Indication, 2019-2029
Figure 112: MEA Neuropathic Pain Management Market Attractiveness Analysis By Distribution Channel, 2019-2029
Figure 113: MEA Neuropathic Pain Management Market Attractiveness Analysis By Country, 2019-2029
